To elucidate the signaling pathways triggered by ACh in breast cancer cell lines, we assessed the activation of the MAPK and PI3K pathways by quantifying the phosphorylation levels of ERK and Akt, respectively. This evidence concerns the gene AKT1 and breast cancer.